KPO: Dialysate Concentrate For Hemodialysis (Liquid Or Powder): FDA Product Code 510(k) Clearances, Predicate Lineage, and Recall History (1978 to 2026)

U.S. FDA CDRH three-letter product classification KPO in Gastroenterology and Urology (21 CFR 876.5820) reconciled across 1978 to 2026.

Review 124 FDA 510(k) clearances, 25 recalled K-numbers, and 113 cumulative 1976 to 2026 CDRH recall notices for KPO: Dialysate Concentrate For Hemodialysis (Liquid Or Powder) on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for KPO: Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
Regulatory MetricVerified Value
Entity ClassificationFDA 3-Letter Product Code (KPO, Class 2)
Clinical Advisory SpecialtyGastroenterology and Urology (Panel GU)
Cleared FDA 510(k) Submissions (1976 to 2026)124 clearances (13 California, 10.5%)
Cleared 510(k)s Linked to a Recall Notice25 K-numbers (20.16% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)113 notices (4 Class I, 96 Class II, 13 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (113 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances0 implantable (0.0%) and 124 life-sustaining
Median FDA 510(k) Review Duration91 days (90th percentile: 269 days)

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.